AHCO - Company ID 0001725255
The table below shows AdaptHealth Corp.'s income statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q3 2026 | Q2 2026 | Q1 2026 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|
| Revenue | $745.65M | $740.31M | $819.80M | $820.31M | $800.37M | $777.88M |
| Cost of revenue | $630.84M | $636.10M | $708.30M | $658.37M | $645.71M | $657.44M |
| Gross profit | - | - | - | - | - | - |
| R&D | - | - | - | - | - | - |
AdaptHealth Corp. reported annual revenue of $3.24B for fiscal year 2025. That is down 0.5% from $3.26B in fiscal 2024. Over the 8 fiscal years shown, annual revenue grew from $345.28M (FY 2018) to $3.24B. Figures come from the company's audited annual reports as filed with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| SG&A |
| $88.66M |
| $96.09M |
| $95.91M |
| $90.11M |
| $97.44M |
| $86.85M |
| Operating income | -$155.92M | -$137.80M | $5.49M | $61.73M | $79.25M | $23.17M |
| Income tax | -$17.49M | -$21.23M | -$5.23M | $10.60M | $35.89M | $850.00K |
| Net income | -$153.99M | -$133.93M | -$16.04M | $24.51M | $14.67M | -$7.21M |
| EPS (diluted) | -$1.13 | -$0.99 | -$0.12 | $0.16 | $0.10 | -$0.05 |